Effect of Low Level Laser Therapy in Patients With Chronic Rhinosinusitis.
CompletedNot applicableNCT05861817
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
This study aimed to evaluate the efficacy of low-level laser therapy (LLLT) for Chronic sinusitis in a randomized, double-blind, placebo-controlled trial.
Study details
- Official title
- Effect of Low Level Laser Therapy on Headache, and Fatigue in Patients With Chronic Rhinosinusitis.
- Interventions
- Device: Laser theapy
- Sponsor
- Cairo University
- Start date
- 2022-01-18
- Primary completion
- 2023-02-01
- Sex
- All
- Age range
- from 19 Years to 40 Years
- Results posted
- No results posted in this snapshot
- Countries
- Egypt
- Total sites listed
- 2
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * patients suffering from mild to moderate symptoms. Exclusion Criteria: * Pregnant or breastfeeding women * Patients with a definite deviated nasal septum, sinusitis, or history of operation within the last 6 months. * Patients with hypertension, diabetes mellitus, malignancy, active pulmonary tuberculosis, infection, active respiratory disease like asthma, or other systemic diseases; • patients with long-term use of corticosteroids or immunosuppressive agents. * Patients with hypersensitivity to the laser. * Patients who were involved in another clinical study within 30 days. * Patients who were unable to comply with the follow-up schedules. * patients who had used antihistamines within 1 week, topical corticosteroids within2 weeks, systemic corticosteroids within 4 weeks, anti-cholinergic drugs within 3 days, antileukotriene drugs within 1 week, decongestants within 3 days, tricyclic antidepressants or phenothiazines within 2 weeks, non-steroidal analgesics within 2 weeks, and other drugs whi
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT05861817